The XJO is expected to open modestly higher this morning, with US markets trading higher again on light volumes overnight. Our market has drifted lower for the past two sessions, though movements have been small. With US markets drifting higher in that time, it is possible we see a little buying today. There isn’t much
Read More
Seasons Greetings from the Team at The Sentiment! We’ll now be taking some time off to enjoy with our families but below are a few of the most popular stories of 2023 and look forward to returning in the New Year. ASX News Scarless healing one step closer as Fiona Wood-led clinical trials demonstrate collagen
Read More
The Australian share market remains in a trading range of 6,500 to 7,500 since 2021 as shown in Figure 1. Over these past three years, there have been market rallies and there have been sell-offs of equal proportions, keeping the market range-bound. As of the writing of this letter on 21 December, the Australian share
Read More
Biotech company PharmAust (ASX: PAA) has been invited by not-for-profit organisation FightMND to submit a comprehensive grant application which could grant up to $1.8 million to fund Phase 2 and 3 clinical trials in an effort to find a treatment for Motor Neurone Disease (MND) Earlier this month, PharmAust submitted a Letter of Intent to
Read More
The XJO is expected to edge higher on open this morning following a small turn around in the U.S last night which saw their market retake much of the previous session’s losses. Their futures are flat. Yesterday we didn’t fall has as much as what our futures were posting this time yesterday morning. Indeed, by
Read More
Picking itself up after a year of losses, financial services company Earlypay Limited (ASX: EPY) has secured a new invoice and trade finance warehouse facility with an initial senior funding commitment limit of $220 million. The financial settlement of the facility is set to take place in January 2024. In addition to this milestone, Earlypay
Read More
